Chiusura precedente | 51,50 |
Aperto | 51,80 |
Denaro | 0,00 x 0 |
Lettera | 0,00 x 0 |
Min-Max giorno | 51,30 - 51,80 |
Intervallo di 52 settimane | 46,50 - 85,60 |
Volume | |
Media Volume | 1.018 |
Capitalizzazione | 7,521M |
Beta (5 anni mensile) | 0,93 |
Rapporto PE (ttm) | 0,20 |
EPS (ttm) | 2,58 |
Prossima data utili | N/D |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
Villers-lès-Nancy, 29 September 2023 - 6:00 p.m. (CET) PRESS RELEASE H1 2023 Results Growth momentum bolstered by favourable market conditions: Revenue: €112.6m, +8.7% Current Operating Income: €27.5m, +6.9% Net profit attributable to Group shareholders: €22.0m, +11.4% Excellent profitability In €m H1 2023H1 2022Change2023/2022Revenue112.6103.5+8.7%Current Operating Income27.525.8+6.9%Net Profit22.9 21.0+9.2%Net Profit attributable to the Group22.019.7+11.4%Basic earnings per share (in € - Attri
Villers-lès-Nancy, 3 August 2023 - 6:00 p.m. (CET) PRESS RELEASE H1 2023 revenue:up 9% to €112.62m Growth by all Divisions, with the exception of FINTECH, which nonetheless benefited from an upturn in Q2.Effects of the French Digital Healthcare investment programme (Ségur du Numérique en Santé) The Group is continuing to install solutions qualifying for the Ségur French Digital Healthcare investment programme: €2m at 30 June 2023.Sales revenues from the recurring portion of the Ségur programme:
Villers-lès-Nancy, 5 July 2023 - 6:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 29 JUNE 2023 Number of shares comprising the share capital: 15,174,125 Number of shares with voting rights: 15,032,834 Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,046,120 That means a quorum of 86.78% of the 15,032,834 shares with voting rights: the Ordinary Annual Gen